US DoD Taps CombiMatrix to Develop Point-of-Care Testing System | GenomeWeb
NEW YORK (GenomeWeb News) – The US Department of Defense has awarded CombiMatrix a fifteen-month contract worth more than $900,000 to develop a hand-held detection system for military use, the company said today.
The contract follows a one-year, $2.2 million agreement the company signed last July with the DoD to develop microarrays to detect pathogens and toxins, and two DoD awards that it won in 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.